The acute and chronic administration of the 5-HT2B/2C receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat:: An in vivo extracellular single cell study

被引:13
作者
Blackburn, TP
Suzuki, K
Ashby, CR
机构
[1] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Allied Hlth Profess, Jamaica, NY 11439 USA
[2] GlaxoSmithKline, Harlow CM19 5AW, Essex, England
[3] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan
关键词
5-HT2C receptors; electrophysiology; dopamine neurons; ventral tegmental area;
D O I
10.1002/syn.20263
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study examined the effect of the acute and chronic administration of the 5-HT2B/2C receptor antagonist N-(1-methyl-5-indolyl)-N'-(3-pyridyl) urea hydrochloride (SB-200646A) on the activity of spontaneously active DA cells in the substantia nigra pars compacta (SNC) and ventral tegmental area (VTA) in anesthetized, male Sprague-Dawley rats. This was accomplished using in vivo extracellular single cell recording. The i.v. administration of 4-16 mg/kg of SB-200646A significantly increased the firing rate and % events as bursts in spontaneously active VTA DA neurons and significantly increased the % events as burst in SNC DA neurons. The acute i.p. administration of 20 and 40 mg/kg of SB-200646A significantly increased the number of spontaneously active VTA DA neurons when compared with vehicle-treated controls. The acute administration of 10 mg/kg of SB-200646A significantly increased the coefficient of variation in spontaneously active SNC and DA neurons when compared with vehicle-treated controls. However, the acute i.p. administration of 20 mg/kg of SB-200646A significantly decreased the degree of bursting of VTA DA neurons. Similary, chronic i.p. administration of 10 mg/kg of SB-200646 did not significantly alter firing, whereas chronic administration of 20 mg/kg of SB-200646A or 20 mg/kg of clozapine significantly decreased the number of spontaneously active VTA DA neurons when compared with vehicle-treated controls. The SB-200646A-induced decrease in the number of spontaneously active VTA DA neurons was reversed by the i.v. administration of (+)-apomorphine or (-)-baclofen. The chronic i.p. administration of either 10 or 20 mg/kg of SB-200646A did not significantly alter the firing pattern of spontaneously active SNC DA neurons. However, the chronic administration of 20 mg/kg of SB-200646A significantly increased the degree of bursting in VTA DA neurons when compared with vehicle. Overall, the acute and chronic administration of SB-200646A produces in vivo electrophysiological effects, resembling that of atypical antipsychotic drugs.
引用
收藏
页码:502 / 512
页数:11
相关论文
共 56 条
[1]   Localization of the 5-hydroxytryptamine(2C) receptor protein in human and rat brain using specific antisera [J].
Abramowski, D ;
Rigo, M ;
Duc, D ;
Hoyer, D ;
Staufenbiel, M .
NEUROPHARMACOLOGY, 1995, 34 (12) :1635-1645
[2]   Modulation of dopamine release by striatal 5-HT2C receptors [J].
Alex, KD ;
Yavanian, GJ ;
McFarlane, HG ;
Pluto, CP ;
Pehek, EA .
SYNAPSE, 2005, 55 (04) :242-251
[3]   THE 5-HT(1A) RECEPTOR SELECTIVE LIGANDS, (R)-8-OH-DPAT AND (S)-UH-301, DIFFERENTIALLY AFFECT THE ACTIVITY OF MIDBRAIN DOPAMINE NEURONS [J].
ARBORELIUS, L ;
CHERGUI, K ;
MURASE, S ;
NOMIKOS, GG ;
HOOK, BB ;
CHOUVET, G ;
HACKSELL, U ;
SVENSSON, TH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (04) :353-362
[4]  
Ashby CR, 1996, SYNAPSE, V24, P349, DOI 10.1002/(SICI)1098-2396(199612)24:4<349::AID-SYN5>3.0.CO
[5]  
2-D
[6]   Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat:: An in vivo extracellular single cell study [J].
Blackburn, TP ;
Minabe, Y ;
Middlemiss, DN ;
Shirayama, Y ;
Hashimot, K ;
Ashby, CR .
SYNAPSE, 2002, 46 (03) :129-139
[7]   Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists:: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent [J].
Bromidge, SM ;
Dabbs, S ;
Davies, DT ;
Davies, S ;
Duckworth, DM ;
Forbes, IT ;
Gaster, LM ;
Ham, P ;
Jones, GE ;
King, FD ;
Mulholland, KR ;
Saunders, DV ;
Wyman, PA ;
Blaney, FE ;
Clarke, SE ;
Blackburn, TP ;
Holland, V ;
Kennett, GA ;
Lightowler, S ;
Middlemiss, DN ;
Trail, B ;
Riley, GJ ;
Wood, MD .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) :1123-1134
[8]   6-chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-indoline (SB-242084): The first selective and brain penetrant 5-HT2C receptor antagonist [J].
Bromidge, SM ;
Duckworth, M ;
Forbes, IT ;
Ham, P ;
King, FD ;
Thewlis, KM ;
Blaney, FE ;
Naylor, CB ;
Blackburn, TP ;
Kennett, GA ;
Wood, MD ;
Clarke, SE .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) :3494-3496
[9]   ACUTE AND CHRONIC HALOPERIDOL TREATMENT - COMPARISON OF EFFECTS ON NIGRAL DOPAMINERGIC CELL ACTIVITY [J].
BUNNEY, BS ;
GRACE, AA .
LIFE SCIENCES, 1978, 23 (16) :1715-1727
[10]  
BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560